A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy Interventions: Drug: riliprubart; Drug: Placebo; Drug: riliprubart; Drug: Placebo; Drug: IVIg; Drug: Placebo; Drug: IVIg premedication Sponsors: Sanofi Not yet recruiting

https://clinicaltrials.gov/study/NCT06290141

Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials

More News: CIDP | Research | Study